Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Streel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Adicciones|December 15, 2010
Recent developments in naltrexone implants and depot injections for opiate abuse: the new kid on the block is approaching adulthoodColin Brewer, Emmanuel Streel
Addiction (Abingdon, England)|October 23, 2018
Long-acting naltrexone has long-acting benefits and 100% induction rates are not difficult to achieveColin Brewer, Emmanuel Streel
Addiction (Abingdon, England)|September 17, 2019
Response to Darke et al. (2019): Circumstances of death of opioid users being treated with naltrexoneEmmanuel Streel, Colin Brewer
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 14, 2020
Is Alcohol in Hand Sanitizers Absorbed Through the Skin or Lungs? Implications for Disulfiram TreatmentColin Brewer, Emmanuel Streel
Journal of Psychopharmacology (Oxford, England)|January 11, 2017
Benzodiazepine maintenance in opiate substitution treatment: Good or bad? A retrospective primary care case-note reviewAdam Bakker, Emmanuel Streel
Addiction Biology|July 10, 2003
Ultra-rapid opiate detoxification: from clinical applications to basic scienceEmmanuel Streel, Paul Verbanck
Addiction Biology|July 2, 2025
Disulfiram Treatment for Alcohol AbuseColin Brewer, Emmanuel Streel
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 9, 2017
Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological AspectsColin Brewer, Emmanuel Streel, Marilyn Skinner
Addiction Biology|March 20, 2002
Towards a comprehension concerning the clinical effects of therapy with rapid opioid detoxificationEmmanuel Streel, Isy Pelc, Paul Verbanck
Addictive Behaviors|October 5, 2013
DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patientsEmmanuel Streel, Christie Chenut, Constentin Papageorgiou, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Adicciones|December 15, 2010
Recent developments in naltrexone implants and depot injections for opiate abuse: the new kid on the block is approaching adulthoodColin Brewer, Emmanuel Streel
Addiction (Abingdon, England)|October 23, 2018
Long-acting naltrexone has long-acting benefits and 100% induction rates are not difficult to achieveColin Brewer, Emmanuel Streel
Addiction (Abingdon, England)|September 17, 2019
Response to Darke et al. (2019): Circumstances of death of opioid users being treated with naltrexoneEmmanuel Streel, Colin Brewer
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 14, 2020
Is Alcohol in Hand Sanitizers Absorbed Through the Skin or Lungs? Implications for Disulfiram TreatmentColin Brewer, Emmanuel Streel
Journal of Psychopharmacology (Oxford, England)|January 11, 2017
Benzodiazepine maintenance in opiate substitution treatment: Good or bad? A retrospective primary care case-note reviewAdam Bakker, Emmanuel Streel
Addiction Biology|July 10, 2003
Ultra-rapid opiate detoxification: from clinical applications to basic scienceEmmanuel Streel, Paul Verbanck
Addiction Biology|July 2, 2025
Disulfiram Treatment for Alcohol AbuseColin Brewer, Emmanuel Streel
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 9, 2017
Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological AspectsColin Brewer, Emmanuel Streel, Marilyn Skinner
Addiction Biology|March 20, 2002
Towards a comprehension concerning the clinical effects of therapy with rapid opioid detoxificationEmmanuel Streel, Isy Pelc, Paul Verbanck
Addictive Behaviors|October 5, 2013
DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patientsEmmanuel Streel, Christie Chenut, Constentin Papageorgiou, et al.
Pageof 2